logo
Select company
Select metric
$ 200.84MOperating Expenses
VS
Market
50
Sector
34
Industry
26
History
40
$ 1.54Close
$ 0.68 - $ 3.19 52-Week Range
Ticker Information

Ticker

FATE

Company Name

FATE THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

FATE THERAPEUTICS INC - Operating Expenses Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

FATE - Op. Exp. Historical data
DateOperating Expenses
6/30/2025$ 200.84M
3/31/2025$ 213.82M
12/31/2024$ 223.91M
9/30/2024$ 210.05M
6/30/2024$ 207.82M
3/31/2024$ 219.47M
12/31/2023$ 254.04M
9/30/2023$ 313.07M
6/30/2023$ 361.22M
3/31/2023$ 399.38M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • FATE THERAPEUTICS INC's latest trailing twelve months (TTM) Op. Exp. stands at $ 142.1M.
  • Over the past 5 years, FATE THERAPEUTICS INC's average Op. Exp. has been $ 262.24M.
  • The median Op. Exp. for FATE THERAPEUTICS INC during this period was $ 229.8M
  • FATE THERAPEUTICS INC reached its highest Op. Exp. over the past 5 years at $ 404.69M.
  • The lowest Op. Exp. recorded by FATE THERAPEUTICS INC in the same timeframe $ 142.1M

FATE THERAPEUTICS INC's Op. Exp. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Op. Exp. Benchmarks
CompanyOp. Exp.
CRVO : CERVOMED INC $ 32.33MTCRX : TSCAN THERAPEUTICS INC $ 151.2MCUE : CUE BIOPHARMA INC $ 47.67MSRZN : SURROZEN INC $ 38.55MKRRO : KORRO BIO INC $ 104.83MOVID : OVID THERAPEUTICS INC $ 48.22MACOG : ALPHA COGNITION INC $ 17.67MARMP : ARMATA PHARMACEUTICALS INC $ 42.2MCBUS : CIBUS INC $ 282.82MCRBU : CARIBOU BIOSCIENCES INC $ 176.72M

Definition of Operating Expenses

[Income Statement] Operating expenses are costs like [SGnA] and [RnD] incurred during regular operations. These costs can either be fixed or variable, and are dependend on the type of business. Common examples are rent, insurance, marketing, and payroll, it excludes cost of revenue [CoR].

FATE - Operating Expenses, Last 5 years

$ 142.1M

Minimum

Sep 30, 2020

$ 404.69M

Maximum

Dec 31, 2022

$ 262.24M

Average

$ 229.8M

Median

Op. Exp. Benchmark Analysis

The chart above depicts the distribution of Op. Exp. for companies in the Total Stock Market. The average Op. Exp. of the companies is $ 232.5M with a standard deviation of $ 271.53M.
The following table provides additional summary stats:
Op. Exp. in the Market:
filtered constituents3.46K
min$ -391.56M
max$ 1.16B
average$ 232.5M
median$ 120.21M
std$ 271.53M